addgene 112022 (Addgene inc)
93
Structured Review
Addgene inc
addgene 112022
Addgene 112022, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/addgene+112022/NYESO+alpha%2Fbeta+into+TRBC1+HDRT+Source+(pTR+262)+(Plasmid+%23112022)/pmc12281410-300-10-10
Average 93 stars, based on 4 article reviews
Addgene 112022, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/addgene+112022/NYESO+alpha%2Fbeta+into+TRBC1+HDRT+Source+(pTR+262)+(Plasmid+%23112022)/pmc12281410-300-10-10
Average 93 stars, based on 4 article reviews
addgene 112022 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Derivative Assay:Article Title: iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors Article Snippet: .. TCRA and TCRB gBlocks of NYESO-1 (clone 1G4), derived from Article Title: iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors. Article Snippet: .. TCRA and TCRB gBlocks of NYESO-1 (clone 1G4), 26 derived from Synthesized:Article Title: iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors Article Snippet: .. TCRA and TCRB gBlocks of NYESO-1 (clone 1G4), derived from Article Title: iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors. Article Snippet: .. TCRA and TCRB gBlocks of NYESO-1 (clone 1G4), 26 derived from |